November 17th 2018The Use of Betrixaban for Extended Prophylaxis of Venous Thromboembolism Events in Hospitalized, High-Risk Patients
Paul P. Dobesh, PharmD Tania Ahuja, PharmD George A. Davis, PharmD Hugh Fatodu, MBA, RPh William H. Francis, MBA, RPh Frank P. Hull, MD Gary L. Johnson, MD, MS, MBA Joshua D. Lenchus, DO, BSPharm Jacqueline Glee Lenoir, PharmD Claudette McPherson, RN, BSN Jeffrey Nemeth, PharmD, MPA Ralph J. Riello III, PharmD